中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 2
Feb.  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(2): 201-204

Public health management strategies： A pathway to eliminating viral hepatitis threats

DOI: 10.12449/JCH250201

  • Chinese Foundation for Hepatitis Prevention and Treatment，Beijing 100106

More Information
  • Corresponding author: WANG Yu， wangyu@chinacdc.cn （ORCID： 0000-0002-7891-4633）
  • Received Date: 2025-01-11
  • Accepted Date: 2025-01-21
  • Published Date: 2025-02-25
    Abstract
  • This article reviews the results of the 2020 national epidemiological survey of chronic viral hepatitis and its public health significance and discusses the differences in standard treatment and management rates and public health management mode between chronic viral hepatitis and AIDS/tuberculosis. Finally， it is proposed that a public health management model should be established to accelerate the elimination of the threats of viral hepatitis and related diseases.

     

    • FullText(HTML)
  • loading
    • References(4)
  • [1]
    ZHENG H, WANG Y, WANG FZ, et al. New progress in HBV control and the cascade of health care for people living with HBV in China: Evidence from the fourth national serological survey, 2020[J]. Lancet Reg Health West Pac, 2024, 51: 101193. DOI: 10.1016/j.lanwpc.2024.101193.
    [2]
    QI XQ, WANG Y. Report on the seroepidemiological survey of hepatitis B in the Chinese population[M]. Beijing: People’s Medical Publishing House, 2011.

    齐小秋, 王宇. 全国人群乙型病毒性肝炎血清流行病学调查报告[M]. 北京: 人民卫生出版社, 2011.
    [3]
    National Health Commission Disease Prevention and Control Bureau, Chinese Center for Disease Control and Prevention. Report on the seroepidemiological survey of hepatitis B among individuals aged 1-29 years in China in 2014[M]. Beijing: People’s Medical Publishing House, 2019.

    国家卫生健康委疾病预防控制局, 中国疾病预防控制中心. 2014年全国1～29岁人群乙型病毒性肝炎血清流行病学调查报告[M]. 北京: 人民卫生出版社, 2019.
    [4]
    ZHENG RS, ZHANG SW, ZENG HM, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2( 1): 1- 9. DOI: 10.1016/j.jncc.2022.02.002.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2241) PDF downloads(104) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return